跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG
Laboratorios Normon S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 7, 2024
Approval ID
6afe50b1bd725c7f
Company
Laboratorios Normon S.A.
Type
Standard
Approval Details
Approval Id
6afe50b1bd725c7f
Drug Cima Aemps Name
VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG
Register Number
89305
Holder Company Name
Laboratorios Normon S.A.
Marketing Company Name
Laboratorios Normon S.A.
Authorization Date
2024-02-07
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Normon S.A.
Active Ingredients
VENLAFAXINA HIDROCLORURO
169,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 7, 2024
Approval ID
6afe50b1bd725c7f
Type
Standard
Back to CIMA-AEMPS Approvals